
TWST Stock Forecast & Price Target
TWST Analyst Ratings
Bulls say
Twist Bioscience is expected to have strong long-term growth driven by their DNA synthesis technology, expansion into multiple businesses using this platform, and growth through their Factory of the Future. They believe that the company's operational scale and ongoing innovations will drive continued revenue growth and gross margin expansion. Additionally, recent developments in AI-driven orders and expanded customer base further strengthen their positive outlook. With a strong focus on cost efficiency and potential for expanding DNA manufacturing capacity, Twist Bioscience is well positioned for continued growth and profitability. Their valuation is based on a sum-of-the-parts method and a strong buy rating is maintained given the opportunities in NGS and AI drug development.
Bears say
Twist Bioscience is highly reliant on its silicon-based DNA synthesis platform, which makes up the majority of its revenue. However, any hiccups in execution or slower progress on key milestones could negatively impact the company's long-term profitability. Additionally, while the company is seeing growth in its core NGS products and in demand from AI-enabled drug discovery, there is a risk that these end markets may not grow as quickly as expected. Overall, there are execution and market growth risks that may lead to lower-than-expected financial performance for Twist Bioscience.
This aggregate rating is based on analysts' research of Twist Bioscience Corp and is not a guaranteed prediction by Public.com or investment advice.
TWST Analyst Forecast & Price Prediction
Start investing in TWST
Order type
Buy in
Order amount
Est. shares
0 shares